These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
569 related items for PubMed ID: 32224127
1. Long noncoding RNA HAND2-AS1 reduced the viability of hepatocellular carcinoma via targeting microRNA-300/SOCS5 axis. Bi HQ, Li ZH, Zhang H. Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):567-574. PubMed ID: 32224127 [Abstract] [Full Text] [Related]
2. LncRNA DHRS4-AS1 ameliorates hepatocellular carcinoma by suppressing proliferation and promoting apoptosis via miR-522-3p/SOCS5 axis. Zhou Y, Li K, Zou X, Hua Z, Wang H, Bian W, Wang H, Chen F, Dai T. Bioengineered; 2021 Dec; 12(2):10862-10877. PubMed ID: 34666613 [Abstract] [Full Text] [Related]
3. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu Q, Tong X, Yang W, Xu Q, Huang D, Tu K. Mol Cancer; 2019 Feb 19; 18(1):28. PubMed ID: 30782188 [Abstract] [Full Text] [Related]
4. lncRNA HAND2-AS1 Inhibits Liver Cancer Cell Proliferation and Migration by Upregulating SOCS5 to Inactivate the JAK-STAT Pathway. Yan D, Jin F, Lin Y. Cancer Biother Radiopharm; 2020 Mar 19; 35(2):143-152. PubMed ID: 32155348 [Abstract] [Full Text] [Related]
5. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway. Bao J, Chen X, Hou Y, Kang G, Li Q, Xu Y. Biomed Pharmacother; 2018 Nov 19; 107():824-833. PubMed ID: 30142544 [Abstract] [Full Text] [Related]
6. lncRNA HAND2-AS1 overexpression inhibits cancer cell proliferation in hepatocellular carcinoma by downregulating RUNX2 expression. Jing GY, Zheng XZ, Ji XX. J Clin Lab Anal; 2021 Apr 19; 35(4):e23717. PubMed ID: 33566427 [Abstract] [Full Text] [Related]
7. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma. Liu W, Zhang GQ, Zhu DY, Wang LJ, Li GT, Xu JG, Jin XL, Zhu YM, Yang XY. Eur Rev Med Pharmacol Sci; 2020 Jul 19; 24(14):7612-7620. PubMed ID: 32744687 [Abstract] [Full Text] [Related]
8. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway. Wu YH, Yu B, Chen WX, Ai X, Zhang W, Dong W, Shao YJ. Aging (Albany NY); 2021 Aug 02; 13(15):19260-19271. PubMed ID: 34341185 [Abstract] [Full Text] [Related]
9. LncRNA DCST1-AS1 functions as a competing endogenous RNA to regulate FAIM2 expression by sponging miR-1254 in hepatocellular carcinoma. Chen J, Wu D, Zhang Y, Yang Y, Duan Y, An Y. Clin Sci (Lond); 2019 Jan 31; 133(2):367-379. PubMed ID: 30617187 [Abstract] [Full Text] [Related]
10. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway. Gao J, Dai C, Yu X, Yin XB, Zhou F. J Cell Biochem; 2021 Jan 31; 122(1):86-99. PubMed ID: 32786108 [Abstract] [Full Text] [Related]
11. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis. Feng Y, Wei G, Zhang L, Zhou H, Wang W, Guo P, Cheng C, Ji L, Cai Q, Feng Y, Tu H. Bioengineered; 2021 Dec 31; 12(1):8217-8232. PubMed ID: 34596006 [Abstract] [Full Text] [Related]
12. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p. Deng Y, Wei Z, Huang M, Xu G, Wei W, Peng B, Nong S, Qin H. J Cell Mol Med; 2020 Jan 31; 24(2):1848-1865. PubMed ID: 31880390 [Abstract] [Full Text] [Related]
13. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis. Huang C, Li K, Huang R, Zhu J, Yang J. Life Sci; 2021 Feb 15; 267():118928. PubMed ID: 33358902 [Abstract] [Full Text] [Related]
14. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis. Fen H, Hongmin Z, Wei W, Chao Y, Yang Y, Bei L, Zhihua S. Curr Pharm Des; 2020 Feb 15; 25(43):4630-4640. PubMed ID: 31692433 [Abstract] [Full Text] [Related]
15. HnRNPU-AS1 inhibits the proliferation, migration and invasion of HCC cells and induces autophagy through miR-556-3p/ miR-580-3p/SOCS6 axis. Zhang L, Zhao Y, Guan H, Zhang D. Cancer Biomark; 2022 Feb 15; 34(3):443-457. PubMed ID: 35275521 [Abstract] [Full Text] [Related]
16. lncRNA OSER1-AS1 acts as a ceRNA to promote tumorigenesis in hepatocellular carcinoma by regulating miR-372-3p/Rab23 axis. Fan J, Zhang J, Huang S, Li P. Biochem Biophys Res Commun; 2020 Jan 01; 521(1):196-203. PubMed ID: 31635804 [Abstract] [Full Text] [Related]
17. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation. Li S, Huang Y, Huang Y, Fu Y, Tang D, Kang R, Zhou R, Fan XG. J Exp Clin Cancer Res; 2017 Apr 12; 36(1):51. PubMed ID: 28403886 [Abstract] [Full Text] [Related]
18. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma. He H, Wang Y, Ye P, Yi D, Cheng Y, Tang H, Zhu Z, Wang X, Jin S. J Exp Clin Cancer Res; 2020 Aug 14; 39(1):159. PubMed ID: 32795316 [Abstract] [Full Text] [Related]
19. Long Non-coding RNA PCED1B Antisense RNA 1 Promotes Cell Proliferation and Invasion in Hepatocellular Carcinoma by Regulating the MicroRNA-34a/CD44 Axis. Bi JG, Li Q, Guo YS, Liu LP, Bao SY, Xu P. Curr Med Sci; 2024 Jun 14; 44(3):503-511. PubMed ID: 38748366 [Abstract] [Full Text] [Related]
20. LncRNA HAND2-AS1 inhibits proliferation and promotes apoptosis of chronic myeloid leukemia cells by sponging with micRNA-1275. Yang JR, Shi MX, Zeng Y. Eur Rev Med Pharmacol Sci; 2019 Mar 14; 23(5):2103-2111. PubMed ID: 30915755 [Abstract] [Full Text] [Related] Page: [Next] [New Search]